Regulating illegal drug markets: what legal markets can teach us

Slides:



Advertisements
Similar presentations
Crohn's disease Prof Daniel C Baumgart, MD, Prof William J Sandborn, MD The Lancet Volume 380, Issue 9853, Pages (November 2012) DOI: /S (12)
Advertisements

Venezuela: violence, human rights, and health-care realities
Volume 390, Issue 10098, Pages (September 2017)
Pharmacogenetics and future drug development and delivery
Thank God for Richard Dawkins?
Simple versus complex COPD: implications for health-care management
Qijin Cheng, Shu-Sen Chang, Paul SF Yip  The Lancet 
Chronic obstructive pulmonary disease (COPD)
Zika: neurological and ocular findings in infant without microcephaly
Cardiovascular disease, chronic kidney disease, and diabetes mortality burden of cardiometabolic risk factors from 1980 to 2010: a comparative risk assessment 
Author gender in The Lancet journals
Infections related to totally implantable venous-access ports
Building neurological services in Africa
Striking cysts: recurrent haematuria in a kickboxer
John N Nkengasong, Philip Onyebujoh  The Lancet 
Frailty assessment in elderly people
Impact of Hyponatremia Correction on the Risk for 30-Day Readmission and Death in Patients with Congestive Heart Failure  Jacques D. Donzé, MD, MSc, Patrick.
A new era for organ transplantation in China
A twin with Cushing's disease
Klebsiella pneumoniae liver abscesses
WHO's budgetary allocation and disease burden
Aspirin in the prevention of cancer – Author's reply
Genetics of lung cancer susceptibility and COPD
Cancer survivorship: a local and global issue
Trends in virological and clinical outcomes in individuals with HIV-1 infection and virological failure of drugs from three antiretroviral drug classes:
Increase in US medication-error deaths
Chronic infections and coronary heart disease
Can plagues be predicted, prevented?
Disease and stigma The Lancet Volume 354, (December 1999)
Arnaud Chiolero  The Lancet Public Health 
Anthony Rodgers, Alistair Woodward, Boyd Swinburn, William H Dietz 
Alcohol-related road traffic injury and Global Burden of Disease 2010
HIV myths should not be resuscitated
Pharmacogenetic testing in the UK clinical setting
Volume 390, Issue 10094, Pages (August 2017)
Volume 385, Issue 9986, Pages (June 2015)
Effect of development assistance on domestic health expenditures
Striking cysts: recurrent haematuria in a kickboxer
Cold water immersion: sudden death and prolonged survival
Metabolic mediators of body-mass index and cardiovascular risk
Volume 97, Issue 1, Pages (January 1990)
Confessions of a journal junkie
Errata The Lancet Infectious Diseases
Fifty years of evolution of the term Down's syndrome
Telling it like it isn't: truth and lies in a post-9/11 world
OVERALL LEADING CAUSES OF DEATH IN THE USA
Chronic obstructive pulmonary disease in non-smokers
Thank God for Richard Dawkins?
Low-technology approaches
Diagnosis of tuberculous meningitis with invasive pulmonary sampling
Do generic correction algorithms produce reliable estimates?
PM2·5: an important cause for chronic obstructive pulmonary disease?
Unjustified regulation prevents use of GMO technology for public good
ACST: which subgroups will benefit most from carotid endarterectomy?
Hospital mortality and staff workload
Prescription for change
Sunku H Guptha, Eric Holroyd, Gordon Campbell
Inhaled triple therapy in chronic obstructive pulmonary disease
Steven A Narod  The Lancet  Volume 349, Issue 9068, (June 1997)
The 2009 influenza pandemic
GBD 2016 estimates problematic for South Africa
Infections related to totally implantable venous-access ports
Difficulties of surgery in the developing world: a personal view
Tapestry of life The Lancet Volume 375, Issue 9723, (April 2010)
Memories of race and place in the USA
Correction to Lancet Gastroenterol Hepatol 2018; 4: 435–44
Symptom-based stratification of autoimmune diseases
Sickle cell disease: a new era
Autism, maths, and sex: the special triangle
A disease of the osteoblast
Presentation transcript:

Regulating illegal drug markets: what legal markets can teach us Tonatiuh Barrientos-Gutierrez, Dèsirée Vidaña-Pérez, Rodrigo Zepeda-Tello, Mauricio Hernández-Ávila  The Lancet  Volume 387, Issue 10037, (June 2016) DOI: 10.1016/S0140-6736(16)30796-6 Copyright © 2016 Elsevier Ltd Terms and Conditions

Figure Deaths by homicide compared with traffic accidents and chronic diseases attributable to alcohol and tobacco use in Mexico 1998–2013 Deaths in Mexico by homicide, alcohol-related traffic accidents (AF 31%), tobacco-related chronic obstructive pulmonary disease (AF 80%), tobacco-related bronchitis (AF 80%), tobacco-related emphysema (AF 80%), and alcoholic liver disease. Data from National Institute of Statistics, Geography, and Informatics. AF=attributable fractions (obtained from the Centers for Disease Control and Prevention). The Lancet 2016 387, DOI: (10.1016/S0140-6736(16)30796-6) Copyright © 2016 Elsevier Ltd Terms and Conditions